Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Czyzak-Gradkowska, A. Nowinski, R. Plywaczewski, P. Bielen, M. Targowska, D. Gorecka, P. Sliwinski (Warsaw, Poland). Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2). Eur Respir J 2013; 42: Suppl. 57, 2536

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence Source: Sleep and Breathing Conference 2021 Year: 2021 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Obstructive sleep apnoea in patients with type 1 diabetes Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Prevalence of obstructive sleep apnoea in men with type 2 diabetes Source: Eur Respir J 2005; 26: Suppl. 49, 567s Year: 2005 Association between plasma haemoglobin A1c (HbA1c) concentration and overnight desaturation in obstructive sleep apnoea (OSA) patients without diabetes Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013 Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015 The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA) Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015 Prevalence of symptomatic gastroesophageal reflux disease (GERD) in severe obstructive sleep apnea (OSA) Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016